Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBYOT.L Regulatory News (BYOT)

  • There is currently no data for BYOT

Trading Statement

6 Oct 2009 07:00

RNS Number : 2761A
Byotrol PLC
06 October 2009
 



Byotrol plc (the "Company")

UPDATE ON TRADING

The Board is pleased to announce a further positive update on trading in relation to the six months ended 30 September 2009.

As highlighted in the announcement dated 17 September, the first half of the current financial year has been characterised by a significant increase in orders for Byotrol products. This trend has continued through to the end of the half year and as a result the Board is pleased to report that product sales for the six months ended 30 September 2009 will be in the order of £1.5m (£0.2m for the comparative period). There was an additional one off license payment of £450k bringing total revenues to approximately £1.9m as compared to £0.4m for the same period last year.

The Board believes certain key factors have underpinned the interest in, and orders for, Byotrol products. One has been the increased public and businesss awareness of the products following the success of the Manchester Royal Infirmary trial which demonstrated that Byotrol outperformed the NHS's gold standard cleaning regime. Another is the increased public awareness of the requirement for better personal hygiene stemming, in part, from the threat of swine flu. The third key factor is the continued growth in the recognition of Byotrol's superiority to other products in that it continues to work even when dry.

Highlights of the Company's activities during the period include the receipt of significant orders for supply to major retailers for the protection of their staff. The Company has also despatched material orders to Arco, one of the UK's leading Health and Safety product suppliers. 

"I am very pleased with the sales performance for the first half" said CEO David McRobbie. "The unprecedented increase in orders gave rise to some temporary issues in relation to sourcing bottles and caps and the Company turned to suppliers in both Europe and North America. This has had an unavoidable short term impact on margins. We have, however, addressed the bottles supply issue via a manufacturing arrangement with a major bottle supplier. Accordingly, the Board expect that margins should improve in the second half of the current financial year."

The eight fold increase in activity levels has also been reflected in an increased working capital requirement and the Board has taken steps to address this. As at 30 September, the Company had cash of £1.6m.

The Company has a good forward order book for the third quarter of the financial year but the nature of the business means that, at the current time, there is more limited visibility for the final quarter. As a consequence, the Board's current view is that the results for the financial year will be in line with market expectations.

The Board will provide a further update at the time of the announcement of the interim results in mid November.

Enquiries:

 

Byotrol plc
 
 
Richard Bell, Finance Director
 
Tel 0161 277 9518
Charles Stanley Securities
Nominated Adviser & Broker
 
 
Philip Davies / Carl Holmes
Tel 020 7149 6000

 

6 October 2009 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUUGAGUUPBPUA
Date   Source Headline
23rd Aug 201811:30 amRNSFinal Results
1st Aug 20187:00 amRNSNotice of Results
17th May 20187:00 amRNSFirst US Retail Trial with Target
10th May 20184:32 pmRNSHolding(s) in Company
10th May 20187:00 amRNSState approval in US
23rd Apr 20183:07 pmRNSHolding(s) in Company
11th Apr 20187:00 amRNSTrading Statement
26th Feb 20183:10 pmRNSHolding(s) in Company
18th Jan 20187:00 amRNSDirector Dealing
14th Dec 20177:01 amRNSKey US Hire & Grant of Options
14th Dec 20177:00 amRNSInterim Results
7th Dec 20177:00 amRNSNotice of Results
10th Nov 20177:00 amRNSGrant of Options & Director/PDMR Shareholdings
28th Sep 201711:49 amRNSResult of AGM
6th Sep 201712:48 pmRNSHolding(s) in Company
6th Sep 201711:37 amRNSForm 8.3 - Byotrol Plc
6th Sep 201711:31 amRNSHolding(s) in Company
5th Sep 20174:37 pmRNSHolding(s) in Company
5th Sep 20174:36 pmRNSHolding(s) in Company
5th Sep 20174:35 pmRNSHolding(s) in Company
4th Sep 201711:57 amRNSResult of General Meeting
31st Aug 20177:00 amRNSResult of Open Offer
30th Aug 20179:24 amRNSPosting of Annual Report and Notice of AGM
29th Aug 20171:19 pmRNSConversion of Loan Notes and Issue of Equity
17th Aug 20172:31 pmRNSHolding(s) in Company
8th Aug 20174:47 pmRNSPlacing & Open Offer Timetable
7th Aug 20179:44 amRNSHolding(s) in Company
3rd Aug 201712:00 pmRNSResult of Proposed Fundraising
3rd Aug 20177:01 amRNSProposed Fundraising
3rd Aug 20177:00 amRNSFinal Results
13th Jun 20177:00 amRNSEPA Approval
13th Mar 20177:00 amRNSAcquisition
6th Feb 20177:00 amRNSDirector Dealing
1st Feb 20177:00 amRNSBoard changes and issue of options
13th Dec 20167:00 amRNSInterim Results
7th Dec 201612:29 pmRNSNotice of Interim Results
14th Oct 20167:00 amRNSGrant of Options and Director Shareholdings
12th Oct 20167:00 amRNSTransfer of Convertible Loan Notes
30th Sep 20163:16 pmRNSResult of Noteholders Meeting
22nd Sep 20164:51 pmRNSResult of AGM
9th Sep 20167:00 amRNSProposed Revision to Loan Notes
18th Aug 20167:00 amRNSFinal Results
8th Jul 20167:00 amRNSTrading Update and Notice of AGM
25th Feb 20167:00 amRNSTrading Statement
19th Feb 20163:34 pmRNSDirector/PDMR Shareholding
3rd Dec 20158:00 amRNSGrant of Options
3rd Dec 20157:00 amRNSInterim Results
9th Sep 201512:06 pmRNSHolding(s) in Company
8th Sep 20154:05 pmRNSResult of AGM and Completion of Placing
24th Aug 20151:57 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.